Search results for "Tumor size"

showing 10 items of 23 documents

Endoscopic ultrasound and early diagnosis of pancreatic cancer

2007

Incidence of pancreatic cancer has increased, but prognosis remains poor. Curative treatment is dependent on early diagnosis. Endoscopic ultrasound (EUS) has been described as highly sensitive and accurate in staging, superior to other imaging modalities in early publications. With rapid advances in technology, other imaging techniques have reached better results. EUS still has the highest accuracy in assessing tumor size and lymph node involvement. For assessment of tumor respectability, a combination of a computed tomography (CT) scan and EUS seems to be the procedure with the highest accuracy. Promising new techniques might improve the diagnostic yield of EUS. But there are several reaso…

Endoscopic ultrasoundeducation.field_of_studymedicine.medical_specialtyPancreatic diseasemedicine.diagnostic_testTumor sizebusiness.industryPopulationUltrasoundGeneral Medicinemedicine.diseasedigestive system diseasesEndoscopymedicine.anatomical_structurePancreatic cancermedicineSurgeryRadiologyeducationbusinessLymph nodeThe American Journal of Surgery
researchProduct

EP756 Laterally extended endopelvic resection: a comparative analysis between laparotomic and laparoscopically modified approach

2019

Introduction/Background Laterally Extended Endopelvic Resection (LEER) has been identified as a valid therapeutic option for women with gynecological malignancies involving the pelvic side wall. The historical approach to LEER is laparotomic, recently we have proposed the so called Laparoscopically Modified Laterally Extended Endopelvic Resection (LM-LEER).The objective of this study is to compare surgical and oncological outcomes between LEER and LM-LEER in a consecutive series of patients with gynecological malignancies infiltrating the pelvic side wall. Methodology We retrospectively evaluated women submitted to LEER between October 2012 and January 2019. Inclusion criteria for LM-LEER w…

High ratemedicine.medical_specialtyTumor sizebusiness.industryTumor resectionMedicineOperative timePerioperativebusinessShort intervalResectionSurgeryePoster
researchProduct

First guidelines for unilateral cT1 renal tumor management

2010

Current treatment options for clinical stage T1 renal tumors, in patients with a contralateral healthy kidney, are diverse. The first guidelines for the management of these lesions have recently been published, which state that tumor size and health status of the patient are important factors to consider. The inclusion of tumor location, patient age and major comorbidities might strengthen these guidelines in the future.

Kidneymedicine.medical_specialtyTumor sizebusiness.industryUrologyTreatment optionsRenal tumorStage t1medicine.diseaseSurgerymedicine.anatomical_structurePatient ageInternal medicineMedicineTumor locationbusinessKidney cancerNature Reviews Urology
researchProduct

Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter

2021

Background: Hepatocellular carcinoma prognosis depends on both liver and tumor determinants, especially on maximum tumor diameter, multifocality, and presence of portal vein thrombosis, despite apparently complete tumor removal by resection or liver transplantation. Aims: To examine parameters of hepatocellular carcinoma aggressiveness as tumor size increases. Methods: A large hepatocellular carcinoma database was examined for trends in serum alpha-fetoprotein and the percentage of patients with macroscopic portal vein thrombosis or tumor multifocality. Results: A total of 13,016 hepatocellular carcinoma patients were identified having full tumor and survival data. Of these, 76.56% were mal…

MaleCancer ResearchPathologymedicine.medical_specialtyCarcinoma HepatocellularPrognosiSettore MED/12 - GASTROENTEROLOGIAClinical BiochemistrysizePathology and Forensic MedicineevolutionmedicineHumansProspective StudiesHCCTumor sizebusiness.industryLiver NeoplasmsCarcinomaSettore MED/09 - MEDICINA INTERNAHepatocellularMiddle AgedPrognosismedicine.diseasePortal vein thrombosisHCC; evolution; size; trendtrendOncologyLiver NeoplasmHepatocellular carcinomaevolution; HCC; size; trendFemalebusinessHuman
researchProduct

Malignant and Unclear Histological Findings in Incidentalomas

2007

<i>Background:</i> The management of incidentalomas with tumor size 3 cm and larger is still under controversial discussion. <i>Study Design:</i> Clinical charts of 65 patients who underwent adrenalectomy for an incidentaloma were reviewed. <i>Results:</i> Sixty-five patients were operated. There were 28 men and 37 women with a median age of 56.9 years. Median size of all resected lesions was 4.1 cm. Indications for surgery were tumor size equal and larger than 3 cm, recurrent pain, hormone status and patients’ fear of malignancy. In 45 patients, the adenomas did not meet the defined criteria of malignancy. There were 9 cases of adrenal hyperplasia, and t…

Malemedicine.medical_specialtyAdenomaAdrenal Gland NeoplasmsAdrenal carcinomaEndoscopic surgeryMalignancyDiagnostic Techniques EndocrineText miningmedicineHumansNeoplasm StagingUltrasonographyIncidental FindingsTumor sizebusiness.industryIncidentalomaGeneral surgeryAdrenalectomyMiddle Agedmedicine.diseaseMagnetic Resonance ImagingHormonesFemaleSurgeryTomography X-Ray ComputedbusinessEuropean Surgical Research
researchProduct

Remnant vital tissue following locoregional therapy for hepatocellular carcinoma: another player in the game

2018

The applicability of liver transplantation (LT) as a curative option for patients with hepatocellular carcinoma (HCC) is limited by organ shortage. In addition to tumor size and number, other variables, particularly those that are surrogates of tumor biology should be incorporated into the allocation policies to improve the estimation of post-LT benefit. In this issue of Transplant International, Manzia et al. analyze the role of remnant vital tissue (RVT) of the target lesion after locoregional therapies (LRT) in predicting post-LT HCC recurrence This article is protected by copyright. All rights reserved.

OncologyTarget lesionTransplantationmedicine.medical_specialtyTumor sizeTumor biologybusiness.industrymedicine.medical_treatmentEconomic shortageImmunosuppressionLiver transplantationmedicine.disease03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisHepatocellular carcinomaInternal medicinemedicine030211 gastroenterology & hepatologybusinessTransplant International
researchProduct

Reply: Selection criteria for liver transplantation in patients with hepatocellular carcinoma: Beyond tumor size and number?

2007

OncologyTransplantationmedicine.medical_specialtyHepatologyTumor sizebusiness.industrymedicine.medical_treatmentLiver transplantationmedicine.diseaseGastroenterologyText miningInternal medicineHepatocellular carcinomamedicineSurgeryIn patientbusinessSelection (genetic algorithm)Liver Transplantation
researchProduct

Application of a new classification to a breast tumor series from a population-based cancer registry: demographic, clinical, and prognostic features …

2009

A new classification based on gene expression profiling or immunohistochemical (IHC) characteristics may replace current histopathological classifications and predict better clinical outcomes. We used IHC markers to classify incident cases ascertained by the Palermo Breast Cancer Registry (2002-2004) into four subtypes: luminal-A (ER+ or PgR+ and HER2/neu-); luminal-B (ER+ or PgR+, HER2/neu+); basal-like (ER-, PgR-, HER2/neu-); and HER2+/ER- (HER2/neu+, ER-, PgR-). We evaluated HER2/neu, ER and PgR in 1300/1985 (65%) cases. The most common IHC-subtype was luminal-A (68%), whereas luminal-B, basal-like, and HER2+/ER- accounted for 14%, 13%, and 5%, respectively. IHC-subtypes were not associa…

Oncologymedicine.medical_specialtyBreast NeoplasmsPopulation basedGeneral Biochemistry Genetics and Molecular BiologyBreast tumorBreast cancerHistory and Philosophy of ScienceInternal medicinemedicineHumansRegistriesskin and connective tissue diseasesGrading (tumors)DemographyGynecologyTumor sizebusiness.industryGeneral NeuroscienceGenes erbB-2Middle Agedmedicine.diseasePrognosisImmunohistochemistryCancer registryMenopauseItalyReceptors EstrogenPopulation SurveillanceImmunohistochemistryFemalebusinessReceptors ProgesteroneAnnals of the New York Academy of Sciences
researchProduct

Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study.

2018

ObjectiveThe identification of patients with endometrial cancer (EC) at higher risk for relapse is critical to individualize and better tailor postoperative treatment. No evidence is available regarding the possible association between tumor size (TS) and the risk of local recurrence. The purpose of this study was to analyze the correlation between TS and risk/type of recurrence in EC patients, stratified according to the new European Society of Medical Oncology-European Society of Gynecological Oncology-European Society for Radiotherapy and Oncology classification.MethodsData of patients with histologically proven EC who received primary surgical treatment between November 1999 and June 20…

Oncologymedicine.medical_specialtyPrognostic factormedicine.medical_treatmentRome03 medical and health sciencesEndometrium0302 clinical medicineEndometrial cancerRetrospective StudieRisk FactorsInternal medicinemedicineLocal recurrenceHumansEndometrial NeoplasmRisk factorAgedRetrospective Studies030219 obstetrics & reproductive medicineReceiver operating characteristicTumor sizebusiness.industryRisk FactorEndometrial cancerDistant relapseLocal relapseObstetrics and GynecologyRetrospective cohort studyTumor sizeMiddle Agedmedicine.diseaseEndometrial NeoplasmsRadiation therapyEndometrial cancer; Local recurrence; Local relapse; Tumor size; Vaginal relapse; Oncology; Obstetrics and GynecologyNeoplasm RecurrenceSettore MED/40 - GINECOLOGIA E OSTETRICIALocalReproductive MedicineOncology030220 oncology & carcinogenesisFemaleNeoplasm Recurrence LocalbusinessVaginal relapseHumanInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society
researchProduct

HETEROGENEOUS OXYGEN TRANSPORT WITHIN MALIGNANT TUMORS

1981

Publisher Summary This chapter discusses the heterogeneous oxygen transport within malignant tumors. Many solid tumors disturbances in the vascularization and in the microcirculation generally lead to distinct restrictions in the convective and diffusive transport. Beyond that, a heterogeneous distribution of the transport conditions develops causing an insufficient and heterogeneous substrate supply as well as an inadequate drainage of wastes. As one of the compulsory manifestations, a poor and heterogeneous oxygen supply becomes more extensively evident with increasing tumor size or age. The polarographic measurements of the local tissue pO 2 values in animal tumors show that very low oxy…

Pathologymedicine.medical_specialtyOxygen supplyLow oxygenTumor sizeChemistrymedicineOxygen transportBiophysicsMouse tumorTumor tissueRegional differencesMicrocirculation
researchProduct